Martijn Gerretsen

544 total citations
16 papers, 477 citations indexed

About

Martijn Gerretsen is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Martijn Gerretsen has authored 16 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Martijn Gerretsen's work include Radiopharmaceutical Chemistry and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Head and Neck Cancer Studies (2 papers). Martijn Gerretsen is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Head and Neck Cancer Studies (2 papers). Martijn Gerretsen collaborates with scholars based in Netherlands, Brazil and United States. Martijn Gerretsen's co-authors include Guus A.M.S. van Dongen, G. B. Snow, Willem Dekker, Gerard W.M. Visser, Chris J. Mulder, Ruud H. Brakenhoff, Jacobus D. M. Herscheid, G. B. Snow, Jasper J. Quak and Richard J. Sinke and has published in prestigious journals such as Nucleic Acids Research, The Journal of Cell Biology and British Journal of Cancer.

In The Last Decade

Martijn Gerretsen

14 papers receiving 469 citations

Peers

Martijn Gerretsen

RNMI

ONCOL

IMMUN

PRM

K Imai Japan

Richard P. McCabe United States

Chirayu Shah United States

Rita Mitnacht‐Kraus Germany

Yiqun Zhang China

G. Landberg Sweden

Hideaki Tsutsumida Japan

Akiko Takada Japan

Marianne Boivin Canada

Eric D. Mortenson United States

K Imai Japan

Martijn Gerretsen

65 ×0.3

RNMI

265 ×1.5

170 ×1.3

ONCOL

129 ×1.7

IMMUN

38 ×0.5

PRM

Citations per year, relative to Martijn Gerretsen Martijn Gerretsen (= 1×) peers K Imai

Countries citing papers authored by Martijn Gerretsen

Since Specialization

Citations

This map shows the geographic impact of Martijn Gerretsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn Gerretsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn Gerretsen more than expected).

Fields of papers citing papers by Martijn Gerretsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn Gerretsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn Gerretsen. The network helps show where Martijn Gerretsen may publish in the future.

Co-authorship network of co-authors of Martijn Gerretsen

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn Gerretsen. A scholar is included among the top collaborators of Martijn Gerretsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn Gerretsen. Martijn Gerretsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mulder, Chris J., Willem Dekker, & Martijn Gerretsen. (1996). Lansoprazole 30mg versus omeprazole 40mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial). European Journal of Gastroenterology & Hepatology. 8(11). 1101–1106. 53 indexed citations

Brakenhoff, Ruud H., Martijn Gerretsen, Helma van Essen, et al.. (1995). The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion.. The Journal of Cell Biology. 129(6). 1677–1689. 126 indexed citations

Gerretsen, Martijn, Jasper J. Quak, Ruud H. Brakenhoff, Gordon B. Snow, & Guus A.M.S. van Dongen. (1994). The feasibility of radioimmunotherapy of head and neck cancer. European Journal of Cancer Part B Oral Oncology. 30(2). 82–87. 4 indexed citations

Gerretsen, Martijn, Gerard W.M. Visser, Ruud H. Brakenhoff, et al.. (1994). Complete ablation of small squamous cell carcinoma xenografts with186Re-labeled monoclonal antibody E48. Cell Biochemistry and Biophysics. 24-25(1-3). 135–142. 15 indexed citations

Gerretsen, Martijn, et al.. (1994). PROGRESS IN RADIOIMMUNOTHERAPY OF HEAD AND NECK-CANCER (REVIEW). Oncology Reports. 1(1). 259–64. 7 indexed citations

Gripp, Flávio M., Jasper J. Quak, H. Leverstein, et al.. (1994). Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.. Pure Amsterdam UMC. 112(3). 612–621.

Quak, Jasper J., et al.. (1994). Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.. PubMed. 13(6B). 2533–9. 5 indexed citations

Gripp, Flávio M., Jasper J. Quak, H. Leverstein, et al.. (1994). Monoclonal antibodies for diagnosis and therapy of squamous cell carcimona of the head and neck. Sao Paulo Medical Journal. 112(3). 612–621.

Gerretsen, Martijn, et al.. (1993). 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.. PubMed. 53(15). 3524–9. 37 indexed citations

10.

Visser, Gerard W.M., Martijn Gerretsen, Jacobus D. M. Herscheid, G. B. Snow, & Guus A.M.S. van Dongen. (1993). Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.. PubMed. 34(11). 1953–63. 75 indexed citations

11.

Gerretsen, Martijn, et al.. (1992). Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG. British Journal of Cancer. 66(3). 496–502. 19 indexed citations

12.

Schrijvers, A. H. G. J., Martijn Gerretsen, Marijke van Walsum, et al.. (1992). Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984. Cancer Immunology Immunotherapy. 34(4). 252–258. 8 indexed citations

13.

Quak, Jasper J., Martijn Gerretsen, A. H. G. J. Schrijvers, et al.. (1991). Detection of Squamous Cell Carcinoma Xenografts in Nude Mice by Radiolabeled Monoclonal Antibody E48. Archives of Otolaryngology - Head and Neck Surgery. 117(11). 1287–1291. 7 indexed citations

14.

Schrijvers, A. H. G. J., Martijn Gerretsen, Marijke van Walsum, et al.. (1991). Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Experimental Cell Research. 196(2). 264–269. 32 indexed citations

15.

Gerretsen, Martijn, et al.. (1991). Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG. British Journal of Cancer. 63(1). 37–44. 19 indexed citations

16.

Wijnen, André J. van, Kenneth L. Wright, Robert F. Massung, et al.. (1988). Two target sites for protein binding in the promoter region of a cell cycle regulated human H1 histone gene. Nucleic Acids Research. 16(2). 571–592. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact